Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Kacerovsky-Strobl, S; Deutschmann, C; Hlauschek, D; Bago-Horvath, Z; Singer, CF; Bartsch, R; Greil, R; Sotlar, K; Rinnerthaler, G; Petru, E; Lax, SF; Egle, D; Pichler, A; Bodó, K; Petzer, AL; Moinfar, F; Weidler, J; Bates, M; Dubsky, P; Gnant, M; Filipits, M.
ESR1, PGR, ERBB2, and MKi67 mRNA expression in diagnostic core biopsies from breast cancer patients of the ABCSG Trial 34.
Breast. 2025; 84:104633
Doi: 10.1016/j.breast.2025.104633
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Bodo Koppány Bonifác
-
Lax Sigurd
-
Moinfar Farid
-
Petru Edgar
-
Rinnerthaler Gabriel
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- AIM: To investigate the performance of the Xpert® Breast Cancer STRAT4 (CE-IVD∗) Assay (STRAT4) in the neoadjuvant, randomized Austrian Breast and Colorectal Cancer Study Group (ABCSG) Trial 34. PATIENTS AND METHODS: The primary objective of this study was to assess the concordance between STRAT4 mRNA measurements of ESR1, PGR, ERBB2, and MKi67 obtained from diagnostic core biopsies of the ABCSG Trial 34 with central reference laboratory immunohistochemistry (IHC) (and in-situ hybridization for HER2 IHC 2+ samples). For each marker, overall percent agreement (concordance), positive percent agreement (sensitivity), and negative percent agreement (specificity) between STRAT4 and IHC were determined. The secondary objective was to evaluate the concordance of STRAT 4 and IHC in post-treatment surgical samples and the association of both assays with residual cancer burden (RCB), time to distant recurrence (DR), and overall survival (OS). Logistic regression and Cox regression models were used. RESULTS: A total of 354 formalin-fixed paraffin-embedded diagnostic core biopsies were examined, representing 88.5 % of the available samples. Concordance between STRAT 4 and IHC was 93.7 % for ER, 80.5 % for PR, and 94.1 % for Ki67. All three biomarkers tested by either STRAT4 or central IHC showed similar correlation to RCB, time to DR, and OS. CONCLUSIONS: In diagnostic core biopsies, there was a good agreement between STRAT4 mRNA measurements and centrally assessed IHC measurements of ER, and moderate agreement for PR and Ki67.